|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Duragesic (fentanyl transdermal system) Alza NDA 19-813/S-023 and S-030 Fentanyl Citrate Injection USP, 0.05 mg (base)/mL Marsam ANDA 74-917 Sublimaze (Fentanyl Citrate) Injection, Akron, NDA 16-619/S32 Sublimaze (Fentanyl Citrate) Injection, Akron, DROPERIDOL; FENTANYL CITRATE Injection 2.5MG/ML;EQ 0.05MG BASE/ML FENTANYL CITRATE AND DROPERIDOL Abbott 019813 FENTANYL Film, Extended Release; Transdermal 0.6MG/24HR DURAGESIC ALZA 019813 FENTANYL Film, Extended Release; Transdermal 1.2MG/24HR DURAGESIC ALZA 019813 FENTANYL Film, Extended Release; Transdermal 1.8MG/24HR DURAGESIC ALZA 019813 FENTANYL Film, Extended Release; Transdermal 2.4MG/24HR DURAGESIC ALZA 019115 FENTANYL CITRATE Injection 0.05MG BASE/ML FENTANYL CITRATE Abbott 072786 FENTANYL CITRATE Injection 0.05MG BASE/ML FENTANYL CITRATE PRESERVATIVE FREE Abbott 016619 FENTANYL CITRATE Injection 0.05MG BASE/ML SUBLIMAZE PRESERVATIVE FREE Akorn MFG 019101 FENTANYL CITRATE Injection 0.05MG BASE/ML FENTANYL CITRATE PRESERVATIVE FREE Baxter | 020747 FENTANYL CITRATE Troche/Lozenge; 0.2MG BASE ACTIQ ANESTA | 020747 FENTANYL CITRATE Troche/Lozenge; 0.4MG BASE ACTIQ ANESTA | 020747 FENTANYL CITRATE Troche/Lozenge; 0.6MG BASE ACTIQ ANESTA | 020747 FENTANYL CITRATE Troche/Lozenge; 0.8MG BASE ACTIQ ANESTA | 020747 FENTANYL CITRATE Troche/Lozenge; 1.2MG BASE ACTIQ ANESTA | 020747 FENTANYL CITRATE Troche/Lozenge; 1.6MG BASE ACTIQ ANESTA | Fentanyl Transdermal System, Mylan Technologies Fentanyl Transdermal System, Mylan | Actiq (oral transmucosal fentanyl citrate), Cephalon, Labeling Revision | Actiq (oral transmucosal fentanyl citrate), Cephalon, Labeling Revision | Fentanyl Transdermal System, Mylan Technologies, Approval | Duragesic (Fentanyl Transdermal System), Alza Corp, New Dosage Regimen | Actiq (oral transmucosal fentanyl citrate), Cephalon, Formulation Revision | Fentanyl Transdermal System, Lavipharm Labs, Approval | Actiq (oral transmucosal fentanyl citrate), Cephalon, Inc., Labeling Revision | FENTORA (fentanyl buccal tablet), Cephalon, Inc., Approval | Fentanyl Transdermal System, Mylan Technologies, New Strength | Actiq (oral transmucosal fentanyl citrate) Lozenge, Cephalon Inc., Patient Population Altered | FENTORA (fentanyl buccal) Tablet, Cephalon Inc., Control Supplement
|